期刊文献+

Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line 被引量:9

Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line
下载PDF
导出
摘要 Objective: Colon cancer stem cells (CSCs) are implicated in colorectal cancer carcinogenesis, metastasis, and therapeutic resistance. The identification of these cells could help to develop novel therapeutic strategies. Doublecortin-like kinase 1 (DCLK1) has been viewed as a marker for gastrointestinal stem cells that fuel the self-renewal process, however others view them as a marker of Tuft cells or as an enteroendocrine subtype. The purpose of this study was to use a colon cancer cell line to identify and characterize the stem-like characteristics of the DCLKI+ cell population. Methods: To enrich stem-like cells, HCT116 cells (derived from colon adenocarcinomas) were cultured using serum-free media to form spheres under both normal oxygen and hypoxia condition. DCLK1 transcript expression in the adherent parental cells and spheroids was quantified using quantitative real time reverse transcription- polymerase chain reaction [(q)RT-PCR]. DCLK1 protein expression was determined using flow cytometry. Self-renewal capability from adherent parental cells and spheroids was determined using extreme limiting dilution analysis (ELDA). Results: Under both normal oxygen and hypoxia condition, the adherent parental cells were composed of cells that express low levels of DCLK1. However, spheroids exhibited an increased frequency of cells expressing DCLK1 on both mRNA and protein levels. Cells derived from spheroids also possess stronger self-renewal capability. Conclusions: The higher fraction of DCLK1 + cells exhibited by spheroids and hypoxia reflects the stem- like characteristics of these cells. DCLK1 may represent an ideal marker to study and develop effective strategies to overcome chemo-resistance and relapse of colon cancer. Objective: Colon cancer stem cells (CSCs) are implicated in colorectal cancer carcinogenesis, metastasis, and therapeutic resistance. The identification of these cells could help to develop novel therapeutic strategies. Doublecortin-like kinase 1 (DCLK1) has been viewed as a marker for gastrointestinal stem cells that fuel the self-renewal process, however others view them as a marker of Tuft cells or as an enteroendocrine subtype. The purpose of this study was to use a colon cancer cell line to identify and characterize the stem-like characteristics of the DCLKI+ cell population. Methods: To enrich stem-like cells, HCT116 cells (derived from colon adenocarcinomas) were cultured using serum-free media to form spheres under both normal oxygen and hypoxia condition. DCLK1 transcript expression in the adherent parental cells and spheroids was quantified using quantitative real time reverse transcription- polymerase chain reaction [(q)RT-PCR]. DCLK1 protein expression was determined using flow cytometry. Self-renewal capability from adherent parental cells and spheroids was determined using extreme limiting dilution analysis (ELDA). Results: Under both normal oxygen and hypoxia condition, the adherent parental cells were composed of cells that express low levels of DCLK1. However, spheroids exhibited an increased frequency of cells expressing DCLK1 on both mRNA and protein levels. Cells derived from spheroids also possess stronger self-renewal capability. Conclusions: The higher fraction of DCLK1 + cells exhibited by spheroids and hypoxia reflects the stem- like characteristics of these cells. DCLK1 may represent an ideal marker to study and develop effective strategies to overcome chemo-resistance and relapse of colon cancer.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2013年第2期134-142,共9页 中国癌症研究(英文版)
关键词 Doublecortin-like kinase 1 (DCLK1) colorectal cancer cancer stem cells stem cell marker SPHEROIDS Doublecortin-like kinase 1 (DCLK1) colorectal cancer cancer stem cells stem cell marker spheroids
  • 相关文献

参考文献49

  • 1Available online: http://www.cancer.org/acs/groups/cid/ documents/webcontent/003096-pdf.pdf.
  • 2American Cancer Society. Colorectal Cancer Facts & Figures. Atlanta, Georgia: American Cancer Society, 2011-2013.
  • 3Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979;189:496-502.
  • 4De Dosso S, Sessa C, Saletti P. Adjuvant therapy for colon cancer: present and perspectives. Cancer Treat Rev 2009;35:160-6.
  • 5Kopetz S, Freitas D, Calabrich AF, et al. Adjuvant chemotherapy for stage II colon cancer. Oncology (Williston Park) 2008;22:260-70; discussion 270, 273,275.
  • 6Marshall JL, Hailer DG, de Gramont A, et al. Adjuvant Therapy for Stage H and HI Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology. Gastrointest Cancer Res 2007;1:146-54.
  • 7de Gramont A, Boni C, Navarro M, et al. Oxaliplatin/5FU/ LV in the adjuvant treatment of stage II and stage HI colon cancer: Efficacy results with a median follow-up of 4 years. J Clin Onco12005;23:abstr 3501.
  • 8Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-84.
  • 9Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001 ;414:105-11.
  • 10Lin SP, Lee YT, Wang JY, et al. Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27. PLoS One 2012;7:e49605.

同被引文献45

  • 1文国容,庹必光,刘华庆,李娟,王雪,刘雪梅,于之昊.IGF-Ⅰ和IGF-Ⅱ在人结直肠腺瘤和结直肠癌中的表达及意义[J].贵州医药,2010,34(12):1069-1071. 被引量:8
  • 2Soresi Maurizio,Giannitrapani Lydia,D'Antona Fabio,Florena Ada Maria,La Spada Emanuele,Terranova Angela,Cervello Melchiorre,D'Alessandro Natale,Montalto Giuseppe.Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(16):2563-2568. 被引量:25
  • 3刘少平,方春华,余立群,何仁胜,喻德林,张险峰.联合检测血清TSGF及CA242和CEA在结直肠癌诊断中的意义[J].中国医师杂志,2007,9(10):1405-1406. 被引量:3
  • 4Keun Hur,Yuji Toiyama,Masanobu Takahashi,Francesc Balaguer,Takeshi Nagasaka,Junichi Koike,Hiromichi Hemmi,Minoru Koi,C Richard Boland,Ajay Goel.MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis[J]. Gut . 2013 (9)
  • 5Suling Liu,Christophe Ginestier,Sing J. Ou.Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks. Cancer Research . 2011
  • 6Wen-Ying Liao,Chih-Chuang Liaw,Yuan-Chao Huang,Hsin-Ying Han,Hung-Wei Hsu,Shiaw-Min Hwang,Sheng-Chu Kuo,Chia-Ning Shen,Hui-Fen Liao.Cyclohexylmethyl Flavonoids Suppress Propagation of Breast Cancer Stem Cells via Downregulation of NANOG[J]. Evidence-Based Complementary and Alternative Medicine . 2013
  • 7Hongmei Sun,Jun Jia,Xiaoli Wang,Bo Ma,Lijun Di,Guohong Song,Jun Ren.CD44 + /CD24 ? breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties[J]. Clinical and Translational Oncology . 2013 (1)
  • 8Hasan Korkaya,Gwang-il Kim,April Davis,Fayaz Malik,N. Lynn Henry,Suthinee Ithimakin,Ahmed A. Quraishi,Nader Tawakkol,Rosemarie D’Angelo,Amanda K. Paulson,Susan Chung,Tahra Luther,Hayley J. Paholak,Suling Liu,Khaled A. Hassan,Qin Zen,Shawn G. Clouthier,Max S. Wicha.Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population[J]. Molecular Cell . 2012 (4)
  • 9Alysha Croker,Alison Allan.Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells[J]. Breast Cancer Research and Treatment . 2012 (1)
  • 10MarcColombel,Colby L.Eaton,FreddyHamdy,EstelleRicci,Gabrivan der Pluijm,MarcoCecchini,FlorenceMege‐Lechevallier,PhilippeClezardin,GeorgeThalmann.Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases[J]. Prostate . 2012 (7)

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部